Cargando…

Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy

Detalles Bibliográficos
Autores principales: Heming, Michael, Wiendl, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962916/
https://www.ncbi.nlm.nih.gov/pubmed/36719925
http://dx.doi.org/10.1073/pnas.2221544120
_version_ 1784896121170034688
author Heming, Michael
Wiendl, Heinz
author_facet Heming, Michael
Wiendl, Heinz
author_sort Heming, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-9962916
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-99629162023-02-26 Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy Heming, Michael Wiendl, Heinz Proc Natl Acad Sci U S A Commentary National Academy of Sciences 2023-01-31 2023-02-07 /pmc/articles/PMC9962916/ /pubmed/36719925 http://dx.doi.org/10.1073/pnas.2221544120 Text en Copyright © 2023 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Heming, Michael
Wiendl, Heinz
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
title Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
title_full Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
title_fullStr Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
title_full_unstemmed Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
title_short Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
title_sort learning multiple sclerosis immunopathogenesis from anti-cd20 therapy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962916/
https://www.ncbi.nlm.nih.gov/pubmed/36719925
http://dx.doi.org/10.1073/pnas.2221544120
work_keys_str_mv AT hemingmichael learningmultiplesclerosisimmunopathogenesisfromanticd20therapy
AT wiendlheinz learningmultiplesclerosisimmunopathogenesisfromanticd20therapy